It can be a self-fulfilling prophecy, some buy on lead up to some data being read-out.. expecting the market to follow... market doesn't because they either haven't heard of CHM or would rather wait for confirmation.. so those who bought early looking for a short term trade are now exiting to chase gains elsewhere.
The volumes traded suggest that is probably what is going on... if there was data leaked.. either positive or negative, volumes would rise sharply.
Since 1 July to yesterday, avg daily volumes were 714k shares traded
Oct month to date trading daily avg volumes are 713k.
For me, all I want to see is some activity and benefit ... because if they see that at the lowest dose, then if they are likely to get a corresponding increase in benefit once they increase the dosage.
If that happens... what that will do to the share price in the short term? I don't know, but it is likely going to generate more interest among investors and those in the oncology field.. having clinical data in humans is much more convincing than preclinical data.
Typically that translates to more people hearing about CHM and hopefully researching CHM.. and once they do that, I'm sure they'll come to the same conclusion as many of us here have.. and that will translate to more demand for the stock.
CHM Price at posting:
30.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)